Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin
Bone Marrow Transplant
2022 | Albert Yeh; Howard Schoch; Fred Appelbaum; H. Joachim Deeg; Mary Flowers; Theodore Gooley; Paul Martin; Kristine Doney; Mohamed Sorror; Barry Storer
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia
Blood
2021 | Wendy Leisenring; Pamela Becker; Brenda Sandmaier; Fred Appelbaum; Barry Storer; Lynn Onstad; Stephanie Lee; Mohamed Sorror; Elihu Estey; Jeannine McCune; Mahmoud Elsawy
Are hematopoietic cell transplant recipients with Gram-negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single centerImmun Inflamm Dis
2021 | Anna Sweet; Steven Pergam; Mohamed Sorror; Catherine Liu; Frank Tverdek; Margaret Lind; Amanda Phipps
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia
Blood
2021 | Fred Appelbaum; Elihu Estey; Stephanie Lee; Mohamed Sorror; Mahmoud Elsawy; Wendy Leisenring; Lynn Onstad; Jeannine McCune; Barry Storer; Pamela Becker; Brenda Sandmaier
Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults
Transplant Cell Ther
2021 | Mohamed Sorror
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation
Transplant Cell Ther
2021 | Mohamed Sorror
Feasibility of geriatric assessment before transplant conditioning regimen in older HCT recipients
Bone Marrow Transplant
2021 | Mohamed Sorror
Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML
Cancer Med
2020 | Mohamed Sorror; Fred Appelbaum; Elihu Estey; Megan Othus; Ylinne Lynch; Pamela Becker; Jennifer Nyland; Mary-Elizabeth Percival
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility
Haematologica
2021 | Pamela Becker; Mary-Elizabeth Percival; Paul Hendrie; Megan Othus; Mohamed Sorror; Elihu Estey; Anna Halpern; Roland Walter; Carole Shaw
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades
Haematologica
2021 | David Maloney; Noa Granot; Boglarka Gyurkocza; H. Joachim Deeg; Mary Flowers; George Georges; Jason Cooper; Thomas Chauncey; George McDonald; Paul Martin; Brenda Sandmaier; Bart Scott; Barry Storer; Marco Mielcarek; Ann Woolfrey; Rainer Storb; Mohamed Sorror
The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer
J Palliat Med
2020 | Mohamed Sorror
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Clin Cancer Res
2019 | Mohamed Sorror; Oliver Press; Mazyar Shadman
Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation
Int J Cardiol
2019 | Mohamed Sorror; Richard Cheng
Revised Acute Myeloid Leukemia Composite Model Using the 2017 European Leukemia Net Risk Classification
JAMA Oncol
2019 | Mohamed Sorror; Jennifer Nyland; Barry Storer; Elihu Estey
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases
Blood
2019 | Mohamed Sorror; Ann Woolfrey; Lauri Burroughs
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
Biol Blood Marrow Transplant
2019 | Mohamed Sorror; Brenda Sandmaier; Mahmoud Elsawy; Fred Appelbaum; Rachel Salit; Rainer Storb; Ann Woolfrey; Colleen Delaney; Filippo Milano; Barry Storer
Pre-transplant expressions of microRNAs, comorbidities, and post-transplant mortality
Bone Marrow Transplant
2019 | Mohamed Sorror; Jesse Hubbard; Antonio Marcondes; Beverly Torok-Storb; Theodore Gooley
Comorbidities, age, and other patient-related predictors of allogeneic hematopoietic cell transplantation outcomes
Expert Rev Hematol
2018 | Mohamed Sorror
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting
Bone Marrow Transplant
2018 | Mohamed Sorror; Rainer Storb
Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia Reply
JAMA Oncol
2018 | Mohamed Sorror; Elihu Estey; Barry Storer
Association of hematopoietic cell transplantation-specific comorbidity index with resource utilization after allogeneic transplantation
Bone Marrow Transplant
2017 | Mohamed Sorror